Massive subchorionic thrombohematoma (Breus' mole): A nationwide retrospective study in Japan
Abstract Objective To estimate the incidence, diagnostic features, and perinatal outcomes of massive subchorionic thrombohematoma (MST) in Japan. Methods This nationwide multicenter retrospective study (2018–2023) analyzed confirmed cases of MST, defined as a laminated hematoma with a maximum thickness ≥1 cm. Maternal characteristics, sonographic patterns, and perinatal complications were evaluated. Results Of 346 741 deliveries across 87 tertiary perinatal centers, 69 pathologically confirmed MST cases were identified at 27 centers, yielding an incidence of 0.019% (69/346 741). Median maternal age was 33 years and body mass index (BMI) was 21.1. Chronic hypertension was present in 8.7% (6/69). Diagnoses occurred antenatally in 81.2% (56/69) and postpartum in 18.8% (13/69). Ultrasound findings included placentomegaly or a placental mass with variable echogenicity. During follow‐up, echogenicity changed in 28% of cases and lesion size in 57%. Perinatal outcomes included induced abortion in 13.0% (9/69), miscarriage before 22 weeks in 5.8% (4/69), stillbirth in 7.2% (5/69), preterm birth in 52.2% (36/69), and term delivery in 21.7% (15/69). Among preterm births, one neonatal death and two infant deaths occurred. After excluding induced abortion and miscarriage before 22 weeks, small‐for‐gestational‐age status was present in 53.6% (30/56) of infants, pre‐eclampsia occurred in 16.1% (9/56), and preterm premature rupture of membranes occurred in 23.2% (13/56). Neonatal intensive care unit admission was required for 82.4% (42/51) of live births. Conclusion MST is a rare but high‐risk placental disorder associated with miscarriage, stillbirth, preterm birth, impaired fetal growth, and pre‐eclampsia. When MST is suspected antenatally, close maternal and fetal surveillance is warranted.
Authors
- 高橋成彦
- Akihiro Hasegawa (ORCID: https://orcid.org/0000-0003-0493-5308)
- Keisuke Tsumura (ORCID: https://orcid.org/0009-0002-6157-2419)
- Tokumasa Suemitsu (ORCID: https://orcid.org/0000-0001-9600-8450)
- Takeshi Nagao (ORCID: https://orcid.org/0000-0002-6056-8824)
- Hiroto Yamamoto (ORCID: https://orcid.org/0000-0001-8739-7570)
- 山本萌子
- Nozomu Yanaihara (ORCID: https://orcid.org/0000-0003-0160-7085)
- Osamu Samura (ORCID: https://orcid.org/0000-0002-7249-1537)
- Sumito Nagasaki (ORCID: https://orcid.org/0000-0002-3007-5295)
- Miyoko Waratani (ORCID: https://orcid.org/0000-0003-3353-6410)
- Hiroki Ishibashi (ORCID: https://orcid.org/0000-0002-8745-6160)
- Rie Oyama (ORCID: https://orcid.org/0000-0003-1228-0145)
- Yuki Ito (ORCID: https://orcid.org/0000-0002-6882-7560)
- Izumi Honda (ORCID: https://orcid.org/0000-0001-5989-3040)
- Tadatsugu Kinjo
- Yukiko Hino
- Ryo Tamaki
- Minako Goto
Institutions
- Jikei University School of Medicine (JP)
- Iwate Medical University (JP)
- University of the Ryukyus (JP)
- Kyoto Prefectural University of Medicine (JP)
- St. Luke's International Hospital (JP)
- Toho University Omori Medical Center (JP)
- Osaka Women's and Children's Hospital (JP)
- SHOWA Medical University Northern Yokohama Hospital (JP)
- Niigata University Medical and Dental Hospital (JP)
- Fukuoka Higashi Medical Center (JP)
- Hokkaido University Hospital (JP)
- Tokyo Metropolitan Tama Medical Center (JP)
- University of the Ryukyus University Hospital (JP)
- National Hospital Organization Saga National Hospital (JP)
- Nara Medical University (JP)
Publication Details
- Journal
- International Journal of Gynecology & Obstetrics
- Published
- 2026-11-14
- DOI
- https://doi.org/10.1002/ijgo.71511
- Primary Topic
- Pregnancy and preeclampsia studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00